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Many tissues if not all are thought to contain stem cells that are responsible for regener-
ation and repair of the tissue after injury. Dysregulation of tissue regeneration may result
in various pathological conditions, among which cancer is the most extensively studied.
Notably, the so-called cancer stem cells or tumor-initiating cells, have been studied in order
to understand the mechanisms of carcinogenesis and/or metastasis. However, the nature
of cancer stem cells, let alone normal stem/progenitor cells, particularly those of the thyroid
remains elusive.There remains a gap in knowledge between adult thyroid stem/progenitor
cells and cancer stem cells of the thyroid, and if and/or how they are related to each other.
Understanding of the mechanism for thyroid regeneration and mode of participation of
normal adult thyroid stem/progenitor cells in this process will hopefully yield a more com-
plete understanding of the nature of thyroid cancer stem cells, and/or help understand the
pathogenesis of other thyroid diseases.This review summarizes the current understanding
of adult thyroid stem/progenitor cells, with particular emphasis on how they contribute to
thyroid regeneration.
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INTRODUCTION
Stem cells can be categorized in three groups; embryonic stem
cells, adult tissue stem/progenitor cells, and cancer stem cells.
Only in recent years, research on all categories of stem cells in
the thyroid field has begun to emerge. Lin et al. for the first time
reported the differentiation of mouse embryonic stem cells into
thyrocyte-like cells in vitro (1). Several in vitro studies followed
examining the effect of TSH, insulin, insulin-like growth factor 1
(IGF1), and/or activin A on differentiation and/or maturation of
embryonic stem cells into thyrocytes (2–6). In 2012 (7), functional
thyroid follicles were successfully generated in vitro from mouse
embryonic stem cells that over express NKX2-1 (also called TTF1)
and PAX8, two transcription factors critical for thyroid develop-
ment (8, 9) and thyroid-specific expression of genes such as those
encoding thyroglobulin (TG), thyroid peroxidase (TPO), TSH
receptor (TSHR), and sodium-iodide symporter (NIS) (10–17).
These in vitro-derived follicles functionally rescued experimentally
induced hypothyroidism in vivo (7).
For the past several years, a number of studies have charac-
terized adult normal thyroid stem/progenitor cells and thyroid
cancer stem cells, the latter using various human thyroid tumors
and tumor cell lines to determine the mechanisms of thyroid
carcinogenesis and/or metastasis (18–22). Yet the nature of thy-
roid cancer stem cells is poorly understood. For instance, it is not
known whether cancer stem cells are the result of thyroid stem cells
acquiring mutations or through epithelial–mesenchymal transi-
tion, or a small portion of cancer cells acquiring properties of
stem cells following dedifferentiation or through other mech-
anisms (23–25). Alternatively, fetal thyroid cell carcinogenesis
theory suggests that cancer cells are directly generated from fetal
cells (26). In order to address these unresolved questions and to
understand the nature and/or role of cancer stem cells in thyroid
carcinogenesis and/or metastasis, characterization of adult normal
thyroid stem/progenitor cells, if present, is of great importance.
Our understanding of adult normal thyroid stem/progenitor cells
may yield a better understanding of various other thyroid diseases
such as thyroiditis in which thyroid tissue stem/progenitor cells
may become activated to repair the damage.
PRESENCE OF ADULT-RESIDENT THYROID
STEM/PROGENITOR CELLS
Thyroid is an organ of slow turnover, estimated to divide only
five times in adulthood (27, 28). The thyroid retains its size and
function that are under control of the physiological negative feed-
back mechanism (27). Following hemithyroidectomy, the residual
thyroid tissue undergoes considerable increase in weight due to
hypertrophy rather than hyperplasia (29). However, in the case
of subtotal thyroidectomy, the presence of hyperplasia was noted
(30), suggesting cell proliferation. The presence of a population of
stem cells that can respond to such proliferation stimulus in vivo
was first postulated in early 1990s (27). This hypothesis was mainly
based on the earlier experimental results showing that thyroid cells
when grafted into thyroidectomized recipient animals, developed
functional thyroid follicles, and the number of follicles formed
or the thyroid function as determined by T3, T4, and TSH levels,
had a direct correlation with the number of cells injected (31–33).
In some of these grafts, thyroid neoplasms including undifferen-
tiated thyroid carcinomas were observed after 10–13 months of
grafts when cells were irradiated while same number of unirradi-
ated cells produced adenomas in 17–22 months (31). These results
were suggestive of the presence of cancer stem cells. Based on this
type of experiment and the fact that foci formation in radiobio-
logical cloning experiments occurred at a very low efficiency, the
frequency of stem cells was estimated at most as 1 in 1000 (27).
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SIDE POPULATION CELLS
An attempt to isolate cells having stem/progenitor characteristics
was first carried out using side population (SP) cells of mouse
thyroid (34). SP cells were originally identified in the adult mouse
bone marrow as a small subset of cells able to efflux the vital dye
Hoechst 33342 in flow cytometric analysis (35). It was later demon-
strated that this was based on the expression of the ATP binding
cassette (ABC) family of transporter proteins in stem/progenitor
cells, which are able to pump out the dye, thus rendering the dye
efflux of SP cells sensitive to inhibitors such as verapamil and
fumitremorgin (36, 37). Various non-hematopoietic adult tissues
were subsequently demonstrated to possess SP cells, including the
liver, skeletal muscle, lung, kidney, and mammary gland (38–45).
SP cells isolated from adult muscle or liver contributed to tissue
regeneration (40, 44), demonstrating that SP cells contain cells
characteristics of stem cells.
Mouse thyroid SP cells were obtained, ranging from 0.3 to
1.4% of the total population of cells. They were composed of two
groups of cells characterized as CD45(−)/c-kit (−)/SCA1(+) and
CD45(−)/c-kit(−)/SCA1(−), each representing approximately a
half of SP cells (34). SCA1 is known to be expressed in SP cells
and/or enriched progenitor cell population from various tissues
such as bone marrow, mammary gland, and muscle (35, 42, 44,
45). Thyroid SP cells expressed stem cell marker genes such as
nucleostemin and Oct4 in addition to Abcg2 through which the
SP fraction of cells were isolated, while thyroid differentiation
marker genes such as Tg, Tpo, Tshr, and two transcription factors
critical for thyroid development and thyroid-specific gene expres-
sion, Nkx2-1 and Pax8 were expressed only in non-SP fraction of
cells as determined by qRT-PCR (34). When SP cells were cul-
tured in three-dimensional (3D) collagen gel in media containing
fetal calf serum (FBS) in vitro, they remained at similar num-
bers for 9 weeks without significant changes in morphology, while
non-SP cells rapidly expanded and spherical structures began to
form at around 3 weeks, which further increased in number and
size by 5 weeks (34). The fact that SP cells remained viable for
9 weeks without any sign of cell death suggested that they may have
stem/progenitor ability, but require correct signal to start prolifer-
ation. Further, histological analysis and immunohistochemistry
of cultured non-SP cells carried out at 9 weeks demonstrated
the presence of follicle-like structures positive for NKX2-1 and
TG. These results revealed that mouse thyroid SP cells exhibit
stem/progenitor cell-like characteristics.
Side population cells were also found in various human thy-
roid cancer cell lines (18). They showed clonogenic ability higher
than non-SP cells in vitro, however in in vivo tumorigenesis assays
using nude mice, tumors were formed in most cases regardless of
cell types. These results suggested that cancer stem cells may not be
identical with cells contained in SP cells obtained from wild-type
mouse thyroids.
OCT4-EXPRESSING CELLS
Monolayer cultures derived from human nodular goiters in media
containing FBS expressed mRNAs encoding stem cell marker
OCT4 and endoderm markers GATA4 and HNF4α for at least
seven passages (46). Addition of TSH to the media did not
change the percentage of OCT4-positive cells, and no cells were
double-positive for OCT4 and GATA4 or HNF4α as judged by
flow cytometric analysis. By use of immunostaining of monolayer
cultures and human thyroid goiter tissues, a very small num-
ber of single isolated cells were present that were positive for
OCT4, GATA4, or HNF4α protein. However, qRT-PCR analysis
of FACS-isolated GATA4 or HNF4α-positive fraction of cells, or
OCT4-positive cells demonstrated the expression of mRNA for
OCT4, or the endodermal markers, respectively, suggesting hetero-
geneous population of OCT4-positive cells; some cells may have
started commitment toward endoderm lineage. The results thus
provided the evidence for the presence of adult stem/progenitor
cells of endodermal origin in human thyroid gland (46).
THYROID PRIMARY SPHERE CULTURE
Side population cells were isolated from human goiters that express
OCT4 and ABCG2, but not other genes HNF4α, GATA4, PAX8,
and TG, TPO, TSHR, and NIS as thyroid differentiation mark-
ers (47). When maintained in monolayer culture or in Matrigel
under serum- and TSH-containing medium for up to 14 days, nei-
ther cell attachment nor growth was observed even under intense
growth stimulation. This situation was somewhat similar to mouse
SP cell cultures as described above, in which stem/progenitor-like
cells remained non-proliferative in monolayer or 3D cultures for
9 weeks (34).
Single cell suspension of primary human thyrocytes from
nodular goiters was cultured in a special serum or TSH free-
medium that allowed formation of floating spherical colonies (47).
These spheres grew in size during first 3–4 days in culture, and
expressed stem cell markers OCT4 and ABCG2, and endodermal
markers GATA4 and HNF4α. The sphere-derived cells contained
SP cells enriched about 50-fold as compared with those before
sphere formation (5 vs. 0.1%, respectively). After 3 days of dif-
ferentiation initiation with serum, sphere-derived cells began to
express TSHR gene, which further intensified in the presence of
both serum and TSH. These sphere-derived cells differentiated
into thyrocytes by day 21, which expressed thyroid differentia-
tion markers, PAX8, TG, NIS, TSHR, and TPO mRNA, but not
stem cells or endodermal markers. Collagen embedded sphere-
derived differentiated cells formed thyroid follicle-like structures,
which displayed TSH-dependent 125iodide uptake, a hallmark of
differentiated thyroid cells.
THYROSPHERES-DERIVED CELL LINES
Thyroid cell aggregates called “thyrospheres” were generated by
culturing fresh surgical human thyroid fragments residual to col-
lagenase digestion in defined media containing EGF and bFGF
(48). Normal thyroid, normal perinodular tissue of the thyroid
adenomas as well as all the different pathological thyroids were
used to generate thyrospheres, from which 23 lines were estab-
lished after 2 months of culture. Twelve such cell lines examined
contained a subpopulation of CD34(+)/CD45(−) cells. When
these spheroid cells were seeded in collagen gels in the presence
of “differentiation medium” containing serum, follicle-like struc-
tures were formed. In contrast, spheroids cultured in “spheroid
culture medium,” follicle-like structures did not form (48). Cells
within the follicles were all positive for TG and the levels of T4 pro-
gressively increased in the supernatant of the spheroids cultured
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in “differentiation medium.” Further, when most freshly isolated
spheroids were co-cultured with a neuroblastoma cell line or in
adipogenic medium, the produced progeny had the expression of
the neuronal marker β-tubulin III or positive staining for oil red O.
These experiments demonstrated that stem/progenitor cells exist
within the thyroid with an intrinsic ability to generate thyroidal
cells and the potential to produce non-thyroidal cells.
All the studies as described provide clear evidence that adult
thyroid indeed possesses stem/progenitor cells although the
real origin of these cells has yet to be determined. Further,
spheres/spheroids formation in serum-free media seems to be
critical as the first step to have isolated stem/progenitor cells dif-
ferentiate into functional thyrocytes in vitro. Indeed, when mouse
and human embryonic stem cells were subjected to differen-
tiation into thyrocytes in serum-free or growth factor-reduced
medium, they went through embryoid bodies, similar in shape as
spheres/spheroids (1, 2, 7, 49). Further, stem cells from other tissue
sources are also often grown in suspension cultures to maintain
stem cell properties (50,51). Taken together, spheres/spheroids for-
mation may provide stem cells the condition that mimics the thy-
roid microenvironment so-called “niche” that regulates activities
of thyroid stem cells in culture (52, 53).
STEM CELLS IN THYROID REGENERATION
Many organs when undergoing partial excision, the remnant fol-
lows compensatory growth involving cellular hypertrophy and/or
hyperplasia (54). Notably, the liver exhibits a remarkable regenera-
tive capacity after partial hepatectomy; the liver mass returns close
to the original weight by 7 days (55). Thyroid gland is among the
organs that exhibit hypertrophy as well as hyperplasia after partial
thyroidectomy (29, 30) although without significant changes in
its size (27). By analogy to partial hepatectomy, partial thyroidec-
tomy may be used to study and understand the mechanisms of
thyroid regeneration even though the gland does not recover its
original size.
PARTIAL THYROIDECTOMY
In the past decades,partial thyroidectomy was mainly used to study
the effect of decreased levels of endogenous thyroid hormone or
exogenously administered thyroid hormone on liver regeneration,
enzymatic activities/functions, or the levels of thyroid hormone-
regulated molecules in the brain, hypothalamus, pituitary, and
liver (56–61). Other studies used partial thyroidectomy to carry
out quantitative analysis of the thyroid function after inoculating
thyroid cells into partial/total thyroidectomized rodents and their
relation to neoplasms (31–33).
A mouse model for thyroid regeneration was established using
partial thyroidectomy to study the effect of partial thyroidec-
tomy on the morphology and gene expression of the remnant
tissues/cells (62). In this study, partial thyroidectomy was carried
out to remove one whole thyroid lobe and ~2/5 caudal segment
of the other lobe. During this study, it was noted that the cen-
tral areas of both thyroid lobes (without partial thyroidectomy)
serve as the proliferative centers where many immature microfol-
licles, and bromodeoxyuridine (BrdU)-positive and/or C cells are
located. One week after partial thyroidectomy, serum TSH levels
were drastically elevated, resulting in a goitrogenesis condition,
which was almost completely resolved by 2 weeks post-partial thy-
roidectomy. At that time, a marked increase of the number of
BrdU-positive cells and cells with clear or faintly eosinophilic cyto-
plasm were observed in the central area and the area continuous
to the cut edge (Figure 1A) (62). Some clear cells were BrdU-
positive, suggestive of active proliferation, and expressed Foxa2,
the definitive endoderm lineage marker (Figure 1B). Microar-
ray followed by pathway analysis revealed that the expression of
genes involved in embryonic development and cancer was affected
by partial thyroidectomy. Electron microscopy demonstrated that
clear cells were scant in cytoplasm, and retained features reminis-
cent of C cells having dense neuroendocrine granules or follicular
cells juxtaposed to a lumen with microvilli. Taken together, clear
cells may be immature cells that were previously C cells or fol-
licular cells that participate in repair, regeneration of the thyroid
gland, and/or goitrogenesis after partial thyroidectomy.
STEM CELL ANTIGEN-1 POSITIVE CELLS
The first evidence of participation of stem cell antigen-1 positive
(SCA-1+) cells in development of thyroid follicles after partial
thyroidectomy was provided by the use of β-galactosidase (β-
gal) reporter mice in conjunction with partial thyroidectomy as
a model for thyroid regeneration, and BrdU long label-retaining
cell analysis (63). The β-gal reporter mice express β-gal in a thyroid
follicular cell-specific fashion upon expression of Cre recombinase
that is controlled by the humanTPO gene promoter. TheTPO pro-
moter is regulated by NKX2-1 (10, 11), and becomes active around
embryonic day (E) 14.5–15.5 of mouse gestation (64), around the
time when thyroid hormone production commences (65). This
indicates that cells expressing β-gal have gone through thyroid
differentiation, thus β-gal mice being able to use in a follicular cell
lineage tracing experiment.
In this study, the main focus was SCA1(+) cells based on the
previous observation that SP cells exhibited stem/progenitor cell-
like characteristics, and a half of them were SCA1(+) (34). Partial
FIGURE 1 | Appearance of clear cells 2 weeks after partial
thyroidectomy. (A) Immunohistochemistry for BrdU (brown color)
counterstained with light H&E. Many clear cells are positive for BrdU as
representatives shown by red arrows. (B) Immunohistochemistry for Foxa2
(brown color), counterstained with hematoxylin. Clear cells expressing
Foxa2 are indicated by arrows.
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thyroidectomy was carried out by removing caudal one-third of
both thyroid lobes as opposed to removing one whole thyroid
lobe and ~2/5 caudal segment of the other lobe used in the study
in which the presence of clear cells were observed (62). In non-
partial thyroidectomized thyroid, SCA1(+) cells were occasionally
found only in vascular endothelial cells. One to two weeks after
partial thyroidectomy, SCA1(+)/BrdU(+), but β-gal(−)/NKX2-
1(−) cells were found in the non-follicular mesenchymal areas
(Figure 2A). They were negative for CD34, suggestive of non-
hematopoietic origin, and also negative for OCT3/4, GATA4,
and SOX10, a marker for stem cells, early endoderm cells, and
neural crest-derived cells, respectively. However, lack of expres-
sion of these genes may have simply been due to missed timing
for detection. Interestingly, they temporarily expressed cytok-
eratin 14 (KRT14), suggesting that they had started acquiring
epithelial features. Some SCA1(+)/BrdU(+)/KRT14(+) cells were
also found in part of follicles at 14 days post-partial thyroidec-
tomy. After partial thyroidectomy, follicles in the area close to
the cut edge became irregular in shape with low or no col-
loid inside, frequently having ciliated intrafollicular cells. The
number of ciliated intrafollicular cells peaked at day 35 through
75 post-partial thyroidectomy. In the affected irregular follicles
at day 35 post-partial thyroidectomy, most intrafollicular cells
were SCA1(+)/BrdU(+)/β-gal(−)/NKX2-1(−), suggesting that
these newly proliferated cells did not originate from previously
differentiated follicular cells and have not yet differentiated to
express NXK2-1 because NKX2-1 regulates TPO gene expres-
sion, on which β-gal expression depends (Figure 2B). However, at
day 120 post-partial thyroidectomy thyroid, some intrafollicular
cells were found to be SCA1(+)/BrdU(+)/β-gal(+)/NKX2-1(+)
(Figure 2C). This suggests that after partial thyroidectomy, the
irregular shaped follicles may become functional follicles express-
ing TPO. It was estimated that only ≤0.1% of intrafollicular cells
expressed SCA1 at day 35 post-partial thyroidectomy that may
have participated in the regeneration and/or differentiation of
thyroid follicular cells after partial thyroidectomy. In this study,
however, it was not possible to demonstrate the origin of SCA1(+)
cells, whether SCA1(+) cells actually migrate from mesenchymal
areas into follicles, and whether SCA1 can be used as a marker for
thyroid stem/progenitor cells. The origin of SCA1(+) cells may be
resident adult thyroid stem/progenitor cells, bone marrow-derived
cells (see below), or cells derived from yet to be determined origins.
That no CD34 expression were found in SCA1(+) cells suggests
against that SCA1(+) cells are bone marrow-derived cells. How-
ever, the possibility cannot be excluded that bone marrow-derived
cells have changed their characteristics after settling in the thyroid
microenvironment that includes loss of CD34 expression. These
questions remain to be answered.
BONE MARROW STEM CELLS
It is known that bone marrow-derived mesenchymal stem cells
are pluripotent progenitors that have self-renewal proliferation
and multipotent differentiation capacity into many lineages of tis-
sues from mesoderm, ectoderm, and endoderm origins, and they
home in response to injury signals (66–68). The mesenchymal
stem cells, however, exhibit high heterogeneity without expression
of specific surface markers (66–68). GFP-expressing bone mar-
row cells derived from C57BL/6 mice were grafted to irradiated
C57BL/6 mice to study whether mesenchymal stem cells partici-
pate in the thyroid gland regeneration after X-ray exposure (69).
GFP-positive signals in cells which co-expressed TG were found
in thyroid follicles at the rate of ~6% when examined at 40 weeks
post-X-ray irradiation at 5 Gy. This was the first demonstration
that bone marrow mesenchymal stem cells indeed participate in
the repair of thyroid after irradiation.
EXPERIMENTAL AUTOIMMUNE THYROIDITIS MODEL
In the experimental autoimmune thyroiditis model mice estab-
lished by immunization with TG, their thyroids were virtually
completely destroyed after a month (70). However, the thyroid
showed remarkable regeneration when observed up to 100 days,
suggesting the presence and activation of adult thyroid stem cells
(70). On day 0 of immunization, the expression of Oct4 was
observed by RT-PCR, the level of which decreased in the thy-
roid of day 35 post-immunization, in keeping with the notion that
OCT4 expression decreases when stem cells begin differentiation
FIGURE 2 | Co-immunofluorescence for SCA1, BrdU, NKX2-1, and β-gal
expression determined at day 7 (A), day 35 (B), and day 120
(C) post-partial thyroidectomy. Colors used were red (SCA1), green (BrdU),
white (NXK2-1), and purple (β-gal). At day 7, red and green co-stained positive
cells [SCA1(+); BrdU(+)] were found in non-follicular mesenchymal area. At
day 35, red/green positive signal was found as an intrafollicular cell, that did
not express NKX2-1 (white), nor β-gal (purple). At day 120, intrafollicular cells
expressing all four proteins were seen. Double or quadruple positive cell in
each panel is shown by an arrow. In (C), strong SCA1 signal is due to cilia that
this SCA1(+) cell has.
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(71). Regeneration was faster in the absence of CD24, possibly
due to the effect of CD24 on the infiltrating lymphocytes. These
mice may provide an alternative model to study the mechanisms
of thyroid regeneration.
SOLID CELL NEST
Solid cell nest (SCN) is the structure believed to be the embry-
onic remnant derived from the ultimobranchial body (UBB) (72).
UBB is the caudal lateral outpocketing from the fourth pharyn-
geal pouches that fuses with thyroid primordium around E14.5
in mouse gestation, giving rise to calcitonin-producing C cells
(73). SCNs were described as an atypical type of follicle charac-
terized in rats and mice as having non-homogenous or foamy
colloid with occasional presence of cilia (74–76). SCNs are in
irregular structures showing squamoid, glandular, or microcystic
features with occasional presence of cilia (77–80) and are located
in the middle third of the thyroid lateral lobes in humans (81).
SCNs are composed of two cell types; “main cells” of polygo-
nal or elongated shape with abundant eosinophilic cytoplasm
and round-to-oval nuclei, and “C cells.” Some SCNs contained
so-called “mixed follicles,” the structure lined by main cells and
follicular epithelium with colloid and/or clumps of eosinophilic
materials in the lumen (77–80). SCNs are often found associated
with Hashimoto’s thyroiditis, a subset of papillary thyroid carci-
nomas, and rare tumors such as mucoepidermoid and squamous
carcinomas of thyroid (77–80, 82).
Studies using histopathological and immunohistochemical
analyses demonstrated the expression of p63 in the main cells
of SCNs in basal/stem cell patterns (78–80). p63 is a member of
the p53 family of transcription factors, and is highly expressed
in the proliferative basal cell layer of stratified epithelia, where
epithelial progenitor cells are thought to reside, including the skin,
breast, esophagus, cervix, urogenital tract, and prostate (83–87).
p63 plays an important role in tumorigenesis, epidermal differ-
entiation, and stem cell self-renewal (86, 87). In addition to p63,
the main cells of SCNs express telomerase and bcl-2 (79), both of
which are known to be associated with stem cells and cancer (88–
90). p63 is a highly specific marker for SCNs, and its expression is
frequently associated with Hashimoto’s thyroiditis and papillary
thyroid carcinomas (78–80). Taken together, it was proposed that
SCNs may represent a pool of stem cells that could contribute to
the histogenesis of C cells and follicular cells, and to thyroid lesions
as described above (77–80, 82).
PRESENCE OF IMMATURE CELLS IN SCN
Ultimobranchial body is composed of two types of cells: one
expressing NKX2-1 and the other expressing p63 (91). Most cells
express NKX2-1 while only a few cells express p63 when examined
at E13.5, the time before UBB fuses with the thyroid primordium
(Figures 3A–C) (91, 92). The NKX2-1-expressing cells do not
overlap with the p63-expressing cells. Using Nkx2-1-null mice
(8), it was demonstrated that NKX2-1-expressing cells were essen-
tial for survival of the UBB cells during its migration to meet
with thyroid primordium, while p63-positive cells could prolifer-
ate in the absence of NKX2-1 expression (91). At E18.5, the latter
cells gave rise to a mass of p63-positive cells in a nested pattern
and/or a cystic vesicular structure that was lined by a monolayer of
p63-negative cells of unknown phenotype, surrounded by a cluster
and/or single layer of p63-positive cells, displaying the basal/stem
cell appearance (Figures 3D,E). Occasionally, ciliated cells were
found in the lining epithelium of the vesicle (Figures 3D,F). This
structure demonstrated a striking similarity in appearance to SCN.
Note that the thyroid primordium cells of Nkx2-1-null mice dis-
integrated through apoptosis (93) and only this cystic structure
remained in Nkx2-1-null mice around the area where the thyroid
was supposed to be located (91, 92). On the other hand, p63 was
not required for the normal development of thyroid gland (92).
The nature of the cystic structure found in Nkx2-1-null mice
was further studied using Nkx2-1; p63-double null mice (92). In
these mice, the p63-positive outer layer of cells surrounding the
cystic vesicular structure or those in nested patterns continued to
the vesicular structure were no longer found. Instead, only p63-
negative single layer cells in tubular or cystic patterns remained,
which appeared dilated (Figures 3F,G) (92). Occasionally, ciliated
cells were observed in the cysts (Figures 3F,G) (92). Cells of the
Nkx2-1;p63-double null UBB cysts were negative for all the follow-
ing markers; neuron-specific enolase and S100 as neuron-specific
markers, OCT4 as a stem cell marker, nestin and SOX10 as a neural
crest marker, and vimentin as a mesenchymal marker. Electron
microscopic examination revealed that the Nkx2-1; p63-double
null UBB were composed of immature cells with scarce cytoplasm
and no clear intracellular organelles or adhesion structures (92).
While the presence of these immature cells were observed only in
Nkx2-1; p63-double null mice, they may always be present within
the thyroid of wild-type mice; whether they are dispersed as indi-
vidual cells throughout the thyroid,or stay clustered within thyroid
remain unknown.
In the partial thyroidectomy model mice, ciliated intrafollic-
ular cells were mainly found in the area where many irregu-
lar shaped follicles were present, which drastically increased in
number after partial thyroidectomy; 1 in 100 intrafollicular cells
had cilia (63), which otherwise were only sporadically found in
fully developed adult thyroids (78–80). Further, in these irregu-
lar follicles, more number of newly differentiated intrafollicular
cells was found after partial thyroidectomy (63). It is possible
that the immature cells found in SCN may represent irregular
shaped follicles with ciliated intrafollicular cells that become func-
tional follicles after partial thyroidectomy. However, these cells do
not express OCT4, suggesting that they may be different from
OCT4-expressing adult-resident thyroid stem/progenitor cells.
MODELS FOR THYROID REGENERATION
Based on what is described above, at least two models for thy-
roid regeneration can be proposed, particularly when the damage
is caused by partial thyroidectomy (Figure 4) (63). Model I:
SCA1(+) newly synthesized [BrdU(+)] non-follicular mesenchy-
mal cells appear after partial thyroidectomy, followed by appear-
ance of SCA1(+); BrdU(+) intrafollicular cells, which eventu-
ally become part of functional follicles. The SCN-like imma-
ture cells that are dormant under normal circumstances, may
become active to collaborate with SCA1(+) cells to participate
in new follicle formation. How this happens and whether a newly
formed follicle further participates in formation of additional fol-
licles remains unknown. SCA1(+) cells may be resident adult
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FIGURE 3 | p63 expression in UBB and SCN of thyroid.
(A–C) Immunofluorescence of E13.5 UBB of wild-type mouse embryos for
NKX2-1 (A) and p63 immunohistochemistry (B), and merged image (C).
Majority of cells express NKX2-1 while a few cells express p63, both being
without overlap. (D,E) SCN from E18.5 Nkx2-1-null embryos for H&E (D) and
p63 immunohistochemistry (E). p63 is expressed in the stem/basal cell
patterns. (F,G) SCN from E18.5 Nkx2-1; p63-double null embryos for H&E
(F) and p63 immunohistochemistry (G). Note that the monolayer of
p63-negative cells remain in SCN from Nkx2-1; p63-double null embryos.
Arrows indicate ciliated cells observed in the cystic structure.
thyroid stem/progenitor cells that have lost OCT4 expression and
acquire SCA1 expression upon stimulation by partial thyroidec-
tomy. Alternatively, SCA1(+) cells could be bone marrow-derived
cells that have changed their characteristics after becoming resi-
dents in the thyroid; after partial thyroidectomy, they are activated
to participate in thyroid regeneration. There could be other mech-
anisms for the appearance of SCA1(+) cells that are currently
unknown. Model I is operative in a situation where thyroid dam-
age caused by partial thyroidectomy is moderate, such as removing
the caudal one-third of both thyroid lobes, and takes 2–4 weeks
to produce new intrafollicular cells. Model II kicks in when the
damage is massive, exceeds the capacity repaired by Model I, and
requires immediate repair to maintain body homeostasis and cor-
rect goitrogenesis condition. This is the case when the thyroid
underwent semi-total partial thyroidectomy (one lobe and 2/5 of
the other thyroid lobe removed), in which previously differentiated
follicular cells and C cells appear to become immature cells and
start contributing thyroid regeneration. This model takes place
within 1–2 weeks. Perhaps resetting many cells to the imma-
ture stage may make the differentiation/maturation proceed more
robustly, resulting in more rapid restoration of thyroid function.
These two thyroid regeneration models somewhat resemble to
those of liver regeneration where one model involves mature liver
epithelial cells (i.e., hepatocytes and cholangiocytes) and the other
involving liver stem/progenitor cells (94–97). The two thyroid
regeneration models may be operable in other damaged situations
than partial thyroidectomy where thyroid requires repair. They
may take place individually or simultaneously, depending on the
extent of injury and regeneration required. Based on our experi-
ence, some clear cells were found in moderately partial thyroidec-
tomized thyroid (Model I), suggesting that the Model II pathway
may always be activated as a supplemental repair mechanism.
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FIGURE 4 |Two models for thyroid regeneration in mice. Model I may
be operable when the damage to the thyroid is modest such as when a
small portion of thyroid (tissues below the line) is removed. This model
may take 2–4 weeks to start producing functionally matured thyrocytes,
and may involve immature cells in SCN. SCA1-expressing cells and
SCN-like immature cells are shown in red and in pale color, respectively.
Ciliated cells are also shown within the immature cells. Model II may
become functional when the thyroid damage is massive such as semi-total
partial thyroidectomy (a whole lobe and the other lobe below the line as
indicated are removed). In this case, follicular cells and C cells are reset to
become clear immature cells (shown in light yellow) to start the
maturation process again. This model may take 1–2 weeks to start
producing functionally mature thyrocytes. Both models can operate
simultaneously. PTx, partial thyroidectomy.
CONCLUSION
We have begun understanding the nature of adult thyroid
stem/progenitor cells and possible mechanisms of their involve-
ment in thyroid regeneration when thyroid is damaged and
requires repair. At least two models for thyroid repair are
proposed involving different types of stem/progenitor cells;
one for mature cells reprogramed back to immature endo-
derm lineage-committed progenitor cells, and the other involv-
ing cells that appear to be adult-resident stem/progenitor cells.
Processes required for tissue repair may have many similar-
ities to cancer development and metastasis, or may provide
insight into the development of various other thyroid diseases.
Understanding normal adult thyroid stem/progenitor cells and
their involvement in thyroid repair should help better under-
stand these diseases, hopefully leading to better diagnosis and/or
treatment.
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